van Doorn PA - Search Results

1

Improving fatigue assessment in immune-mediated neuropathies: the modified Rasch-built fatigue severity scale.

van Nes SI, Vanhoutte EK, Faber CG, Garssen M, van Doorn PA, Merkies IS; PeriNomS Study Group. van Nes SI, et al. Among authors: van doorn pa. J Peripher Nerv Syst. 2009 Dec;14(4):268-78. doi: 10.1111/j.1529-8027.2009.00238.x. J Peripher Nerv Syst. 2009. PMID: 20021568

2

Psychometric evaluation of a new handicap scale in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, Van Der Meché FG, Samijn JP, Van Doorn PA. Merkies IS, et al. Among authors: van doorn pa, van der meche fg. Muscle Nerve. 2002 Mar;25(3):370-7. doi: 10.1002/mus.10045. Muscle Nerve. 2002. PMID: 11870713

3

Treatment of immune neuropathies.

Van Doorn PA, Garssen MP. Van Doorn PA, et al. Curr Opin Neurol. 2002 Oct;15(5):623-31. doi: 10.1097/00019052-200210000-00014. Curr Opin Neurol. 2002. PMID: 12352007 Review.

4

Screening for anti-ganglioside antibodies in hypocretin-deficient human narcolepsy.

Overeem S, Geleijns K, Garssen MP, Jacobs BC, van Doorn PA, Lammers GJ. Overeem S, et al. Among authors: van doorn pa. Neurosci Lett. 2003 Apr 24;341(1):13-6. doi: 10.1016/s0304-3940(03)00085-5. Neurosci Lett. 2003. PMID: 12676332

5

Comparison between impairment and disability scales in immune-mediated polyneuropathies.

Merkies IS, Schmitz PI, Van Der Meché FG, Van Doorn PA. Merkies IS, et al. Among authors: van doorn pa, van der meche fg. Muscle Nerve. 2003 Jul;28(1):93-100. doi: 10.1002/mus.10410. Muscle Nerve. 2003. PMID: 12811779 Clinical Trial.

6

Sensory exam with a quantitative tuning fork: rapid, sensitive and predictive of SNAP amplitude.

Merkies IS, Schmitz PI, van Doorn PA. Merkies IS, et al. Among authors: van doorn pa. Neurology. 2004 Sep 28;63(6):1138; author reply 1138. doi: 10.1212/wnl.63.6.1138. Neurology. 2004. PMID: 15452325 No abstract available.

7

Associations with autoimmune disorders and HLA class I and II antigens in inclusion body myositis.

Badrising UA, Schreuder GM, Giphart MJ, Geleijns K, Verschuuren JJ, Wintzen AR, Maat-Schieman ML, van Doorn P, van Engelen BG, Faber CG, Hoogendijk JE, de Jager AE, Koehler PJ, de Visser M, van Duinen SG; Dutch IBM Study Group. Badrising UA, et al. Neurology. 2004 Dec 28;63(12):2396-8. doi: 10.1212/01.wnl.0000148588.15052.4c. Neurology. 2004. PMID: 15623710

8

Treatment of Guillain-Barré syndrome and CIDP.

van Doorn PA. van Doorn PA. J Peripher Nerv Syst. 2005 Jun;10(2):113-27. doi: 10.1111/j.1085-9489.2005.0010203.x. J Peripher Nerv Syst. 2005. PMID: 15958124 Review.

9

Distinguishing acute-onset CIDP from Guillain-Barré syndrome with treatment related fluctuations.

Ruts L, van Koningsveld R, van Doorn PA. Ruts L, et al. Among authors: van koningsveld r, van doorn pa. Neurology. 2005 Jul 12;65(1):138-40. doi: 10.1212/01.wnl.0000167549.09664.b8. Neurology. 2005. PMID: 16009902

10

Conduction velocity distribution in neurologically well-recovered but fatigued Guillain-Barré syndrome patients.

Garssen MP, Blok JH, van Doorn PA, Visser GH. Garssen MP, et al. Among authors: van doorn pa. Muscle Nerve. 2006 Feb;33(2):177-82. doi: 10.1002/mus.20451. Muscle Nerve. 2006. PMID: 16270305 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

427 results

Search Page

Filters